News by subject: Share Issue

Spire Global, Inc. ("Spire" or "the Company"), a leading global provider of space-based data, analytics and space services, today announced that it has filed an S-3 shelf registration statement with the Securities and Exchange Commission ("the...

PotlatchDeltic Corporation ("PotlatchDeltic") announced today the successful completion of the previously announced merger of CatchMark Timber Trust, Inc. ("CatchMark") with PotlatchDeltic in an all-stock transaction, creating a leading integrated...

Teucrium Trading, LLC, the Sponsor of agricultural futures-based ETFs, today announced that the 2021 Schedule K-3(s) reflecting items of international tax relevance are available online. Unitholders requiring this information may access their...

Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to three new employees. On September 13, 2022, the Compensation Committee of Savara's Board of Directors...

NanoVibronix, Inc. ("Nano" or the "Company"), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that its Board of Directors declared a dividend of one...

Edgewise Therapeutics, Inc., today announced that it intends to offer and sell shares of its common stock in an underwritten public offering of $100 million of its common stock. In addition, Edgewise Therapeutics intends to grant the underwriters a...

Securitize, a leading digital asset securities firm, today announced the launch of a fund tokenizing an interest in KKR's Health Care Strategic Growth Fund II ("HCSG II") on the Avalanche public blockchain. This is a major step toward making...

Innovative Solutions and Support, Inc. ("IS&S" or the "Company") today announced that its Board of Directors (the "Board") has adopted a stockholder rights plan and declared a dividend distribution of one preferred share purchase right on each...

Alnylam Pharmaceuticals, Inc. ("Alnylam") , the leading RNAi therapeutics company, announced today that it has commenced a private offering of $900 million aggregate principal amount of convertible senior notes due 2027 (the "notes") to persons...

Arcus Biosciences, Inc. , an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company's Board of Directors granted ten new employees options to...

DLQ, Inc., a provider of digital consumer acquisition solutions ("DLQ"), and a wholly-owned subsidiary of Logiq, Inc. , today announced it has entered into a definitive merger agreement ("Merger Agreement") for a business combination whereby it will...

Global Business Travel Group, Inc. (the "Company" or "GBTG") , the world's leading B2B travel platform, today announced that it has commenced an exchange offer (the "Offer") and consent solicitation (the "Consent Solicitation") relating to its...

UroGen Pharma Ltd. a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units ("RSUs") to 10 new employees in...

Horizon Therapeutics plc today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares. "This share repurchase program reinforces the confidence we have in our strategy and our...

BlackRock Corporate High Yield Fund, Inc. (the "Fund") today announced that its Board of Directors (the "Board") has approved the terms of the issuance of transferable rights ("Rights") to the holders of shares of the Fund's common stock (par value...

Regulatory News: Nanobiotix (Paris:NANO) : Market: Euronext Paris / Nasdaq Euronext Compartment: B ISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website: www.nanobiotix.com Date Number of Shares Outstanding...

Olo Inc. , a leading open SaaS platform for restaurants that enables hospitality at every touchpoint, today announced that its board of directors authorized a share repurchase program for up to $100,000,000 of the Company's Class A common stock. The...

Regulatory News: In accordance with resolutions 18 and 19 approved by the Shareholders' Meeting on July 21, 20221, the Board of Directors of Rémy Cointreau (Paris:RCO) decided to authorize the Group's Chief Executive Officer to implement a share...

SMART Global Holdings, Inc. ("SGH") , today announced that the independent Compensation Committee of the Board of Directors of SGH has approved the grant, as of August 29, 2022, of restricted share units ("RSUs") with respect to an aggregate of...

Puma Biotechnology, Inc. , a biopharmaceutical company, announced that on September 1, 2022, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 18,750 shares of Puma common...

Kezar Life Sciences, Inc., , a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company's Board of Directors...

Biocept, Inc. , a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 89,550 shares of its common stock to 12 new employees. The inducement...

PotlatchDeltic Corporation announced today that its Board of Directors approved a new $200 million share repurchase program. This program replaces the existing $100 million share repurchase program authorized in August 2018. "Returning cash to our...

Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a biotechnology company focused on progressing Psychedelics to Therapeuticstm, is pleased to announce that Adelia Therapeutics Inc. ("Adelia"), a wholly-controlled subsidiary of Cybin, has achieved...

Lightning eMotors, Inc. , a leading provider of zero emission medium-duty commercial vehicles and electric vehicle technology for fleets, today announced that the Company has entered into a purchase agreement and registration rights agreement...

Coyuchi, the first organic luxury home goods brand for sustainable living, announces today the opportunity for the general public to invest through a Regulation A+ offering for the first time in its 30+ year history. This Regulation A+ offering has...

Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the preliminary results of its rights offering which expired at 5:00...

Perma-Pipe International Holdings, Inc. announced today that on July 26, 2022, it cancelled 239,168 shares of treasury stock representing all the treasury shares held by the Company on that date. On October 4, 2021, the Board of Directors authorized...

Bloom Energy Corporation today announced the closing of an underwritten public offering of 14,950,000 shares of Class A common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions. The shares of Class A...

FuboTV Inc. , the leading sports-first live TV streaming platform, today announced that on August 16, 2022, the Compensation Committee of FuboTV's Board of Directors granted restricted stock unit awards covering an aggregate of 40,283 shares of its...

Geron Corporation today reported that it has granted non-statutory stock options to purchase an aggregate of 365,800 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company....

Food solutions company SpartanNash (the "Company") today reported financial results for its 12-week second quarter ended July 16, 2022. Second Quarter Fiscal 2022 Highlights Net sales of $2.3 billion, increased 7.9%, compared to $2.1 billion in...

Bloom Energy Corporation today announced the pricing of its underwritten public offering of 13,000,000 shares of Class A common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions. All of the shares of...

Bloom Energy Corporation today announced that it has commenced an underwritten public offering of 13,000,000 shares of its Class A common stock. All of the shares of the Class A common stock are being offered by Bloom Energy. In addition, Bloom...

Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced the closing of its previously...

First Seacoast Bancorp , the holding company for First Seacoast Bank, announced today that the Board of Directors of its parent mutual holding company, First Seacoast Bancorp, MHC, has adopted a Plan of Conversion and Reorganization pursuant to which...

Silence Therapeutics plc ("Silence"), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced the pricing...

Mirum Pharmaceuticals, Inc. today announced that on August 10, 2022, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 28,250 shares of common stock and 14,100...

Ellington Residential Mortgage REIT (the "Company") today reported financial results for the quarter ended June 30, 2022. Highlights Net loss of $(10.7) million, or $(0.82) per share. Adjusted Distributable Earnings1 of $3.7 million, or $0.28...

Broadstone Net Lease, Inc. , ("BNL"), today announced that it is commencing an underwritten public offering of 13,000,000 shares of Common Stock, par value $0.00025 per share, in connection with the forward sale agreements described below. BNL...

Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced the pricing of its previously...

Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it has commenced an...

Dalliance Services Company, a corporation incorporated under the laws of the Marshall Islands (the "Offeror") and wholly owned by Sergey Solonin, the controlling shareholder and chairman of the board of directors of QIWI PLC, a company formed under...

OPAL Fuels Inc. , a vertically integrated producer and distributor of renewable natural gas (RNG), today announced the closing of a five-year, $105 million senior secured debt facility. The facility provides construction financing for designated OPAL...

Karuna Therapeutics, Inc. ("Karuna"), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it has commenced an...

Axonics, Inc. ("Axonics"), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the closing of its public offering of 2,012,500 shares of its...

TriplePoint Venture Growth BDC Corp. (the "Company") today announced that it has priced an underwritten offering of 3,750,000 shares of its common stock at a price to the public of $13.75 per share for total gross proceeds of approximately...

Guild Holdings Company ("Guild" or the "Company"), a growth-oriented mortgage company that employs a relationship-based loan sourcing strategy to execute on its mission of delivering the promise of homeownership, today announced results for the...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of an aggregate of...

Syros Pharmaceuticals , a leader in the development of medicines that control the expression of genes, today announced the grant of a restricted stock unit (RSU) award for 31,000 shares of Syros common stock to one newly hired employee in connection...